Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Pain, Postoperative 4 Pituitary Neoplasms 3 Neoplasms 2 Liver Neoplasms 2 Delirium 2 Central Nervous System Diseases 2 Brain Neoplasms 2 Supratentorial Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Rectal Neoplasms 1 Pituitary Diseases 1 Pancreatic Neoplasms 1 Pain 1 Neuroinflammatory Diseases 1 Neurofibromatoses 1 Neurocognitive Disorders 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hypoxia 1 Hydrocephalus 1 Headache 1 Epilepsy 1 Colonic Neoplasms 1 Chronic Pain 1 Agnosia 1 Abdominal Neoplasms 1 Abdominal Cancer Surgery 1 Abdominal Cancer Surgeries 1

Interventions

Propofol 6 Carboplatin 5 Sevoflurane 4 Saline Solution 3 Paclitaxel 3 Nivolumab 3 Erlotinib Hydrochloride 3 Acetaminophen 3 Pemetrexed 2 Midazolam 2 Lidocaine 2 Isoflurane 2 Docetaxel 2 Desflurane 2 Cryotherapy 2 Bupivacaine 2 Bronchoscopy 2 Anesthesia, Inhalation 2 trametinib 1 sotorasib 1 pegfilgrastim 1 icotinib 1 endostar protein 1 durvalumab 1 dabrafenib 1 capmatinib 1 camrelizumab 1 beta Carotene 1 atezolizumab 1 alectinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lung Neoplasms × Dexmedetomidine × Clear all

NCT01381627 2013-02-28

EBUSed

Maisonneuve-Rosemont Hospital

Phase 4 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡